Ignite Creation Date:
2024-05-06 @ 4:39 PM
Last Modification Date:
2024-10-26 @ 2:13 PM
Study NCT ID:
NCT05043246
Status:
UNKNOWN
Last Update Posted:
2022-08-10
First Post:
2021-08-12
Brief Title:
Safety and Immune Response of COVID-19 Vaccination in Patients With Basic Disease
Sponsor:
The Second Affiliated Hospital of Chongqing Medical University
Organization:
The Second Affiliated Hospital of Chongqing Medical University
Study Overview
Official Title:
Safety and Immune Response of COVID-19 Vaccination in Patients With Basic Disease
Status:
UNKNOWN
Status Verified Date:
2022-08
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
SIM-PBD
Brief Summary:
On 11 February 2020 the International Committee for the Classification of Viruses named the disease caused by SAＲS-CoV-2 infection in humans as the new coronavirus pneumonia coronavirus disease 2019 COVID-19Due to the decline of immunity and cardiopulmonary function in patients with basic diseases hypertension diabetes chronic obstructive pulmonary disease chronic kidney disease cancer diseases etc COVID-19 s severe illness and mortality mainly increase in these special population Vaccination of COVID-19 vaccine can effectively prevent COVID-19 virus infection and delay or prevent patients from developing into critical illness and reduce mortalityTo evaluate the safety and effectiveness of the population vaccinated with COVID-19 vaccine and to play a scientific and theoretical supporting role in guiding COVID-19 vaccination scientifically reasonably and effectively so this study was carried out
Detailed Description:
Due to the decline of immunity and cardiopulmonary function in patients with basic diseases hypertension diabetes chronic obstructive pulmonary disease chronic kidney disease cancer diseases etc COVID-19 s severe illness and mortality mainly increase in these special population At present there is no evidence that these special population have been vaccinated against COVID-19 but CDC vaccination and the guidelines and consensus of various professional societies hold that 1 the people with underlying diseases have low immunity and are easy to develop into severe patients with high mortality 2 although there is no direct evidence of evidence-based medicine it is best to be vaccinated with COVID-19 vaccine in the absence of disease progression activities to reduce high risk To evaluate the safety and effectiveness of the population vaccinated with COVID-19 vaccine and to play a scientific and theoretical supporting role in guiding COVID-19 vaccination scientifically reasonably and effectively so this study was carried out
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None